Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicine company, and Pfizer, Inc. (NYSE: PFE), today announced updated follow-up results from the Phase 1/2 Alta study evaluating investigational SB-525 gene therapy in patient(full story)
Comtex SmarTrend(R) via COMTEX - Tue Dec 03, 12:57PM EST
Pfizer Inc (NYSE:PFE) traded in a range yesterday that spanned from a low of $37.84 to a high of $38.05. Yesterday, the shares fell 1.1%, which took the trading range below the 3-day low of $38.25 on volume of 693,000 shares. O(full story)
Comtex SmarTrend(R) via COMTEX - Tue Dec 03, 12:57PM EST
Pfizer Inc (NYSE:PFE) traded in a range yesterday that spanned from a low of $37.84 to a high of $38.05. Yesterday, the shares fell 1.1%, which took the trading range below the 3-day low of $38.25 on volume of 693,000 shares. O(full story)
NavaDerm Partners ("NavaDerm" or the "Company"), a Northeast-focused dermatology services company and portfolio company of BelHealth Investment Partners ("BelHealth"), a New York-based healthcare private equity firm, announced the(full story)
Pfizer Inc. invites investors and the general public to listen to a webcast of a discussion with Mikael Dolsten, Chief Scientific Officer and President, Worldwide Research, Development and Medical, and Michael Vincent, Senior Vice(full story)